ACS | Control | |
---|---|---|
Gender (M/F) | 60/12 | 44/8 |
Age (years) | 63 ± 10 (42–85) | 62 ± 5 (54–73) |
BMI (kg/m2) | 27.5 ± 3.8 (20.6-40.8) | 27.9 ± 3.6 (21.6-40.5) |
WC (cm) | 101 ± 10 (70–137) | 100 ± 9 (80–118) |
Prevalence (%) | ||
Hypertension | 68 | 62 |
Dyslipidemia | 70 | 62 |
Type 2 Diabetes | 16 | 12 |
Medications (%) | ||
ACE-Inhib or ARB | 48 | 42 |
Ca-Channel Blocker | 18 | 20 |
Beta-Blockers | 44 | 38 |
Diuretics | 16 | 20 |
Statins | 34 | 30 |
ASA | 38 | 24 |
SBP (mmHg) | 131 ± 18 (95–175) | 136 ± 16 (115–165) |
DBP (mmHg) | 72 ± 10 (55–100) | 76 ± 6 (70–95) |
Creat (mg/dl) | 1.01 ± 0.28 (0.55-1.5) | 0.92 ± 0.20 (0.60-1.4) |
Tg (mg/dl) | 126 ± 65 (44–585) | 146 ± 35 (110–289) |
T-Chol (mg/dl) | 191 ± 42 (81–316) | 215 ± 41 (127–261) |
HDL-Chol (mg/dl) | 45 ± 8 (24–85) | 48 ± 8 (32–65) |
Glucose (mg/dl) | 121 ± 26 (60–221) | 114 ± 10 (86–131) |
Insulin ( μU/ml) | 4.6 ± 2.4 (1.5-12) | 5.4 ± 3.3 (1.2-15.4) |
HOMA-IR | 1.45 ± 0.95 (0.3-4.8) | 1.50 ± 0.96 (0.5-3.8) |
CK (mU/ml) | 124 (8.4-888) | - |
Troponin (ng/ml) | 14.6 (0.5-326) | - |
CRP (mg/dl) | 2 (0.2-15) | 0.2 (0.02-3.1)* |
PTX3 (ng/ml) | 5.7 (1.8-29.3) | 2.7 (1.2-5.6)* |